TITLE

Unrealistic optimism created ethical dilemma in early-phase cancer trials

AUTHOR(S)
Fisher, Stacey L.; Sharer, Emily; Volansky, Rob
PUB. DATE
February 2011
SOURCE
Hem/Onc Today;2/25/2011, Vol. 12 Issue 4, p25
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article discusses the ethical dilemma concerning the early phase cancer trial conducted by The Hastings Center in the U.S. in which the participating patients have unrealistic optimism that can affect their informed consent in 2011.
ACCESSION #
62393628

 

Related Articles

  • Truth Telling and Advance Planning at the End of Life: Problems with Autonomy in a Multicultural World. Candib, Lucy M. // Families, Systems & Health: The Journal of Collaborative Family ;Fall2002, Vol. 20 Issue 3, p213 

    Focuses on the impact of biomedical culture's approach on information disclosure to patients diagnosed with cancer in the U.S. Advantages and disadvantages of patient disclosure; Details on cross-cultural issues at the end of life; Information on the preference of families in not disclosing...

  • Autonomy in a Relational Context: Balancing Individual, Family, Cultural, and Medical Interests. Quill, Timothy E. // Families, Systems & Health: The Journal of Collaborative Family ;Fall2002, Vol. 20 Issue 3, p223 

    Comments on the biomedical culture's approach of information disclosure to patients with cancer in the U.S. Role of physicians in presenting the patient with choices concerning life; Significance of seeking autonomy in relation to family and culture regarding patient disclosure and medical...

  • Medical Malpractice: Informed Consent--Arato v. Avedon.  // American Journal of Law & Medicine;1993, Vol. 19 Issue 3, p355 

    Focuses on the duty of a physician to obtain informed consent from his patient without disclosure of life expectancy information according to the Supreme Court of California. Administration of the doctrine of informed consent for a patient with pancreatic cancer; Judgment of the jury on the...

  • Psychosocial Issue Related to the Care of Adolescents With Cancer. Ritchie, Mary Ann; O'Neil, J. Anne; Daller, Ruth T. // Oncology Nursing Forum;May2000, Vol. 27 Issue 4, p611 

    Discusses factors to be considered when constructing a developmentally relevant plan of care for adolescent patients with cancer. Suggestions for effective psychosocial nursing care interventions; Need to discuss treatment options with the patient; Importance of informed consent.

  • Expanding the Reach of Clinical Trials. Carroll-Johnson, Rose Mary // Oncology Nursing Forum;Sep2000, Vol. 27 Issue 8, p1197 

    Editorial. Discusses progress being made in clinical trials. Involvement of cancer patients in clinical trials; Ethical aspects of patient care in regard to informed consent, truth telling and placebo use during a clinical trial.

  • Phase I participants’ views of quality of life and trial participation burdens. Jacquelyn Slomka; Anne Flamm; David Gold; Roy Herbst; James Abbruzzese // Supportive Care in Cancer;Jul2007, Vol. 15 Issue 7, p885 

    Abstract Purpose  Participants’ perception of quality of life (QOL) and respondent burden have significant implications for investigators’ ethical responsibilities to their subjects in phase I cancer trials. To address these responsibilities, analysis was conducted on...

  • Assessment of clinical relevant fatigue level in cancer. Yoon Chang; Jung Lee; Chang Lee; Won Lee; Keun Lee; Soo-Mee Bang; Xin Wang; Tito Mendoza; Charles Cleeland; Young Yun // Supportive Care in Cancer;Jul2007, Vol. 15 Issue 7, p891 

    Abstract Goals of work  Fatigue is highly prevalent in cancer and greatly inferences with daily life. The goal of this study was to identify the most informative score in the Brief Fatigue Inventory and to define cut points for “mild,” “moderate,” and...

  • The Importance of Being Earnest. Lynch, John J. // Journal of Hospital Ethics;Winter2012/2013, Vol. 3 Issue 2, p58 

    The article discusses the importance of honesty in medical practice. It is stated that to have a healthy and trusting relationship with patients and families, a physician has to tell the truth from the beginning. Physicians should give information to patients in a compassionate and truthful...

  • Penn-developed online informed consent tool could boost number of patients in cancer clinical trials.  // Biomedical Market Newsletter;10/10/2011, Vol. 21, p260 

    The article reports that the 53rd Annual Meeting of the American Society for Radiation Oncology at the University of Pennsylvania will discuss a new informed consent tool available in the Internet which will increase cancer patients' participation in clinical trials.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics